Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M.
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):61-85. doi: 10.1002/ijgo.13878.
Ovarian cancer development and metastasis.
Lengyel E.
Am J Pathol. 2010 Sep;177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22.
Imaging of primary fallopian tube carcinoma.
Shaaban AM, Rezvani M.
Abdom Imaging. 2013 Jun;38(3):608-18. doi: 10.1007/s00261-012-9920-4.
Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.
Bergsten TM, Burdette JE, Dean M.
Cancer Lett. 2020 Apr 28;476:152-160. doi: 10.1016/j.canlet.2020.02.017. Epub 2020 Feb 15.
Fallopian Tube Neoplasia and Mimics.
Kolin DL, Nucci MR.
Surg Pathol Clin. 2019 Jun;12(2):457-479. doi: 10.1016/j.path.2019.01.006.
Cancer of the ovary, fallopian tube, and peritoneum.
Berek JS, Kehoe ST, Kumar L, Friedlander M.
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:59-78. doi: 10.1002/ijgo.12614.
The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
Soong TR, Howitt BE, Horowitz N, Nucci MR, Crum CP.
Gynecol Oncol. 2019 Feb;152(2):426-433. doi: 10.1016/j.ygyno.2018.11.033. Epub 2018 Nov 30.
Current management of fallopian tube carcinoma.
Gadducci A.
Curr Opin Obstet Gynecol. 2002 Feb;14(1):27-32. doi: 10.1097/00001703-200202000-00005.
Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers.
Matsuoka A, Tate S, Nishikimi K, Iwamoto M, Otsuka S, Shozu M.
In Vivo. 2022 Sep-Oct;36(5):2453-2460. doi: 10.21873/invivo.12980.
[Fallopian tube: the dark face of pelvic carcinogenesis].
Watkin E, Devouassoux-Shisheboran M.
Ann Pathol. 2011 Oct;31(5):345-52. doi: 10.1016/j.annpat.2011.06.008. Epub 2011 Sep 25.
